BRD2 and endometrial cancer: In this study, our data show that the numbers of premenopausal patients with excess levels of FSH or LH were higher in both type 1 and type 2 endometrial cancer, suggesting that excess FSH or LH contributes to higher levels of estrogen in endometrial cancer.